Loading
A phase 3 trial of Methotrexate and Pentostatin in Acute lymphoblastic leukaemia and Leukaemia, run by St. Jude Children's Research Hospital, completed.
Methotrexate or Pentostatin for Graft-versus-host Disease Prophylaxis in Risk-adapted Allogeneic Bone Marrow Transplantation for Hematologic Malignancies is a phase 3 interventional study registered as NCT01188798 by St. Jude Children's Research Hospital, with 6 participants recorded, started 2010-09 and reaching its primary completion in 2012-02. Interventions recorded: Methotrexate, Pentostatin. Conditions recorded: Acute Lymphoblastic Leukemia, Acute Myelocytic Leukemia, Chronic Myelocytic Leukemia, Hodgkin's Disease, Myelodysplastic Syndrome.
Linked to the drug Pentostatin because the registry names it among its interventions and Acute lymphoblastic leukaemia and Leukaemia among its conditions. Registry record only: no result has been read by an editor.
The full inclusion and exclusion criteria are on the registry record. Read 2026-10-07. Recruiting overall does not mean a particular site is open; ask the study team.
ClinicalTrials.gov data courtesy of the US National Library of Medicine.
Shares Pentostatin and the tag pipeline.
Shares Leukaemia (all types), Acute lymphoblastic leukaemia and the tag pipeline.
Shares Pentostatin and the tag pipeline.
Shares Acute lymphoblastic leukaemia and the tag pipeline.
Shares Acute lymphoblastic leukaemia and the tag pipeline.
Shares Acute lymphoblastic leukaemia and the tag pipeline.
Shares Acute lymphoblastic leukaemia and the tag pipeline.
Shares Methotrexate, Leukaemia (all types), Acute lymphoblastic leukaemia and the tag pipeline.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/